SCHEMBL1246475

SCHEMBL1246475

Cc1cc(-c2noc(C)c2NC(=O)OCCc2ccccc2F)ccc1-c1ccc([C@@H](C)C(=O)O)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 5/20 0.41
SCN5A Q14524 4/20 0.41
AKR1C3 P42330 2/20 0.39
AKR1C2 P52895 2/20 0.39
PTGS2 P35354 3/20 0.39
FAAH O00519 2/20 0.39
PTGS1 P23219 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
MAPT P10636 2/20 0.38
CYP2C19 P33261 2/20 0.38
LMNA P02545 2/20 0.38
FABP2 P12104 1/20 0.38
TSHR P16473 1/20 0.38
AKR1C4 P17516 1/20 0.38
ADRA2B P18089 1/20 0.38
CHRM3 P20309 1/20 0.38
HTR2C P28335 1/20 0.38
DRD3 P35462 1/20 0.38
AKR1C1 Q04828 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1246243 0.91 SCN9A (0.44) SCN9ASCN5APTGS2FAAHMAPT
SCHEMBL1247390 0.91 SCN9A (0.44) SCN9ASCN5APTGS2FAAHMAPT
SCHEMBL2338472 0.88 LPAR1 (0.44) AKR1C3AKR1C2PTGS2FAAHPTGS1
SCHEMBL1247167 0.85 SCN9A (0.43) SCN9ASCN5AMEN1KMT2AMAPT
SCHEMBL11895802 0.83 LPAR1 (0.42) SCN9ASCN5AAKR1C3AKR1C2PTGS2
SCHEMBL11895801 0.83 LPAR1 (0.42) SCN9ASCN5AAKR1C3AKR1C2PTGS2
SCHEMBL1247241 0.82 SCN9A (0.55) SCN9ASCN5APTGS2MAPTNTRK1
SCHEMBL1245118 0.82 SCN9A (0.55) SCN9ASCN5APTGS2MAPTNTRK1
SCHEMBL2338258 0.81 LPAR1 (0.41) SCN9ASCN5APTGS2FAAHMEN1
SCHEMBL2337612 0.80 LPAR1 (0.51) SCN9ASCN5AAKR1C3AKR1C2PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2462128-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-06-13 EP claimed
WO-2011017350-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-02-10 WO claimed